Medicover AB 2017 AR2
The report highlights Medicover's financial and operational performance for the fiscal year 2017, marking its first year as a listed company on Nasdaq Stockholm. The company achieved a revenue of EUR 580.2 million, representing a 16.7% growth, and exceeded one million members subscribing to its Integrated Healthcare Model. Key developments included expanding operations into India through the acquisition of a fertility business and investing in MaxCure Hospital Group. Additionally, Medicover launched its first digital histopathology platform in Romania and continued its focus on sustainability, focusing on prevention, quality of care, and environmental initiatives.
Company: Medicover AB
Sector: Professional & technical services
Country: Sweden
Year: 2017
Type: AR2
Pages: 112
Back to company
Medicover AB
Annual Report
The report highlights Medicover's financial and operational performance for the fiscal year 2017, marking its first year as a listed company on Nasdaq Stockholm. The company achieved a revenue of EUR 580.2 million, representing a 16.7% growth, and exceeded one million members subscribing to its Integrated Healthcare Model. Key developments included expanding operations into India through the acquisition of a fertility business and investing in MaxCure Hospital Group. Additionally, Medicover launched its first digital histopathology platform in Romania and continued its focus on sustainability, focusing on prevention, quality of care, and environmental initiatives.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2017
Reporting Period
Jan 1, 2017 - Dec 31, 2017
Fiscal Year
2017
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees